Tendai is a Director of Value & Evidence at Pfizer inc. She has over 10 years of experience in delivering health outcomes strategies that demonstrate clinical and economic value of new medicines and vaccines. Tendai holds PhD in Theoretical Immunology from Utrecht University in the Netherlands, a master’s in applied mathematics from the University of Cape Town in South Africa and a Post-graduate diploma from AIMS-South Africa. Tendai is a qualified high school biology and mathematics teacher. She is passionate about access and quality of mathematics and science education so spends her time outside of work on mentoring young women with an interest in STEM as well as teaching mathematical modelling courses across Africa. In her professional life Tendai focuses mainly on treatments and vaccines for infectious diseases. Before joining Pfizer, Tendai developed health economic models at the UK Health Security Agency (UKHSA) to assess the value of public health interventions of controlling tuberculosis spread among populations with difficulties in accessing health care. Prior to joining UKHSA Tendai focused on the within host dynamics of infectious disease using dynamic models of lymphocytes and immunes responses to HIV and Flu infections in academia at Imperial college London, The University of Rochester Medical Center and Utrecht University.